Outset Medical Appoints Industry Veteran Kevin O'Boyle to its Board of Directors

Company Overview - Outset Medical, Inc. is a medical technology company focused on pioneering technology to reduce the cost and complexity of dialysis [4] - The company's flagship product, the Tablo® Hemodialysis System, is FDA cleared for use from hospital to home, representing a significant advancement in dialysis technology [4] - Tablo integrates water purification and on-demand dialysate production, allowing it to function as a mobile dialysis clinic with 2-way wireless data transmission and a proprietary data analytics platform [4] Leadership Changes - Kevin O'Boyle has been appointed to the Board of Directors and as chair of the Audit Committee, bringing over 20 years of healthcare leadership experience [2][3] - O'Boyle's previous roles include CFO of several publicly traded companies and board director of six public medical device companies, which will aid Outset in its growth [2] - Dale E. Jones has stepped down from the Board, with appreciation expressed for his contributions during a critical period for the company [3]